An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) will report its first quarter 2024 financial results on May 6, 2024. The company will host a conference call and webcast to discuss the financial results and provide a corporate update.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) pubblicherà i risultati finanziari del primo trimestre del 2024 il 6 maggio 2024. La società organizzerà una conferenza telefonica e un webcast per discutere i risultati finanziari e fornire un aggiornamento aziendale.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) reportará sus resultados financieros del primer trimestre de 2024 el 6 de mayo de 2024. La empresa realizará una llamada de conferencia y una transmisión en web para discutir los resultados financieros y proporcionar una actualización corporativa.
BioCryst Pharmaceuticals, Inc. (나스닥: BCRX)는 2024년 5월 6일에 2024년도 1분기 재무 결과를 보고할 예정입니다. 회사는 재무 결과를 논의하고 기업 업데이트를 제공하기 위해 콘퍼런스 콜과 웹캐스트를 주최할 것입니다.
BioCryst Pharmaceuticals, Inc. (Nasdaq : BCRX) publiera ses résultats financiers pour le premier trimestre de 2024 le 6 mai 2024. L'entreprise organisera une conférence téléphonique et un webcast pour discuter des résultats financiers et fournir une mise à jour de la société.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) wird seine Finanzergebnisse für das erste Quartal 2024 am 6. Mai 2024 bekannt geben. Das Unternehmen wird eine Telefonkonferenz und ein Webcast veranstalten, um die Finanzergebnisse zu diskutieren und ein Unternehmensupdate bereitzustellen.
Positive
None.
Negative
None.
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024.
BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.
The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.
About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
When will BioCryst Pharmaceuticals report its first quarter 2024 financial results?
BioCryst Pharmaceuticals will report its first quarter 2024 financial results on May 6, 2024.
How can I access the conference call hosted by BioCryst Pharmaceuticals?
The conference call hosted by BioCryst Pharmaceuticals can be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers.
Where can I find the live webcast and replay of the call by BioCryst Pharmaceuticals?
The live webcast and replay of the call by BioCryst Pharmaceuticals will be available online in the investors section of the company website at www.biocryst.com.
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
